| Clinical data | |
|---|---|
| Other names | 5-Methoxy-N-methyl-(α,N-trimethylene)tryptamine; CP-108509; CP108509 |
| Drug class | Serotonergic psychedelic; Hallucinogen |
| ATC code |
|
| Legal status | |
| Legal status | |
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| ChemSpider |
|
| UNII | |
| ChEMBL | |
| CompTox Dashboard (EPA) | |
| Chemical and physical data | |
| Formula | C15H20N2O |
| Molar mass | 244.338 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
| | |
5-MeO-MPMI (developmental code name CP-108509), also known as 5-methoxy-N-methyl-(α,N-trimethylene)tryptamine, is a psychedelic drug of the pyrrolidinylmethylindole and cyclized tryptamine families.[1]
Interactions
[edit]Pharmacology
[edit]Pharmacodynamics
[edit]
5-MeO-MPMI produces psychedelic-appropriate responding in animal tests, with similar potency to DOI.[1] It has two enantiomers, with only the (R)-enantiomer being active.[1]
Chemistry
[edit]Analogues
[edit]Analogues of 5-MeO-MPMI include MPMI, 4-HO-MPMI, 5-fluoro-MPMI, 5-MeO-pyr-T, CP-122288, CP-135807, and eletriptan, among others.
History
[edit]5-MeO-MPMI was first developed by the team led by J. E. Macor and colleagues in 1992.[2] It was subsequently investigated by the team led by David E. Nichols from Purdue University in the late 1990s.[1]
Society and culture
[edit]Legal status
[edit]5-MeO-MPMI is not a controlled substance in Canada as of 2025.[3]
See also
[edit]References
[edit]- 1 2 3 4 Gerasimov M, Marona-Lewicka D, Kurrasch-Orbaugh DM, Qandil AM, Nichols DE (1999). "Further studies on oxygenated tryptamines with LSD-like activity incorporating a chiral pyrrolidine moiety into the side chain". Journal of Medicinal Chemistry. 42 (20): 4257–4263. CiteSeerX 10.1.1.690.4941. doi:10.1021/jm990325u. PMID 10514296.
- ↑ Macor JE, Blake J, Fox CB, Johnson C, Koe BK, Lebel LA, Morrone JM, Ryan K, Schmidt AW, Schulz DW, et al. (1992). "Synthesis and serotonergic pharmacology of the enantiomers of 3-[(N-methylpyrrolidin-2-yl)methyl]-5-methoxy-1H-indole: discovery of stereogenic differentiation in the aminoethyl side chain of the neurotransmitter serotonin". Journal of Medicinal Chemistry. 35 (23): 4503–4505. doi:10.1021/jm00101a032. PMID 1447752.
- ↑ "Controlled Drugs and Substances Act". Department of Justice Canada. Retrieved 19 January 2026.
External links
[edit]| Tryptamines |
|
|---|---|
| 4-Hydroxytryptamines and esters/ethers |
|
| 5-Hydroxy- and 5-methoxytryptamines |
|
| N-Acetyltryptamines |
|
| α-Alkyltryptamines |
|
| α-Ketotryptamines | |
| Cyclized tryptamines |
|
| Isotryptamines | |
| Related compounds |
|